6月16日 - ** 制药商IncyteINCY.O股价上涨4.4%至79.69美元
** INCY周日表示， (link)，其实验性血癌疗法显示，它可以靶向清除癌细胞，同时保留健康细胞，从而有可能恢复正常的血液生产
** 该疗法可治疗一类血液疾病，这种疾病的特殊基因突变会导致血细胞不受控制地繁殖。
** 86%的患者在接受较高剂量的实验性疗法后，血细胞计数有了明显改善，其中大多数(82%) 之前升高的血小板水平完全恢复正常
** INCY 计划与监管机构会面，目标是在 2026 年初开始晚期试验
** 包括盘中走势在内，INCY股价今年累计下跌0.9%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.